Cerebral embolic protection devices are "compelling," researchers wrote, but current data does not suggest they make a significant impact on patient outcomes.
Nursing technology leaders at a large health system are reporting time savings of 20.6 minutes per nurse across 12-hour shifts while caring for an average of 4.5 patients each. The secret to their success: automated digital documentation.
Both treatment options are effective, but metabolic and bariatric surgery was linked to more significant cardiovascular risk reductions than GLP-1 medications.
When a TAVR valve fails and that patient undergoes redo TAVR, are there benefits to choosing one device type over the other? The team behind a new study tracked multiple outcomes and identified specific factors that may help predict survival.
About 38% of rads surveyed said they had defended against at least one lawsuit, with such specialists at a higher risk than others in internal medicine.
Legal and compliance teams have to serve as sentinels sizing up potential legal exposure points without turning into needlers who only slow down clinical innovation.
Rather than test artificial intelligence's ability to detect malignant lesions on imaging, researchers instead recently explored how it impacts radiologists' interpretation processes.
New research suggests the technique can effectively break down amyloid fibrinogen microclots, which are believed to interfere with perfusion and cause inflammation.
“We are in a crisis with healthcare research, administrative burdens, and with payment. Access for our patients is hurt," said American Medical Association (AMA) Board of Trustees member Scott Ferguson, MD, FACR.
Cerebral embolic protection devices are "compelling," researchers wrote, but current data does not suggest they make a significant impact on patient outcomes.
Nursing technology leaders at a large health system are reporting time savings of 20.6 minutes per nurse across 12-hour shifts while caring for an average of 4.5 patients each. The secret to their success: automated digital documentation.
Both treatment options are effective, but metabolic and bariatric surgery was linked to more significant cardiovascular risk reductions than GLP-1 medications.
